HLS Therapeutics Inc. (TSX:HLS)
Canada
· Delayed Price · Currency is CAD 4.340
+0.110 (2.60%)
Apr 28, 2025, 3:59 PM EDT
HLS Therapeutics Revenue
In the year 2024, HLS Therapeutics had annual revenue of $56.62M USD, down -10.23%. HLS Therapeutics had revenue of $15.54M in the quarter ending December 31, 2024, a decrease of -2.02%.
Revenue
$56.62M
Revenue Growth
-10.23%
P/S Ratio
1.69
Revenue / Employee
$615.42K
Employees
92
Market Cap
137.98M CAD
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 56.62M | -6.46M | -10.23% |
| Dec 31, 2023 | 63.07M | 1.61M | 2.61% |
| Dec 31, 2022 | 61.47M | 1.46M | 2.43% |
| Dec 31, 2021 | 60.01M | 3.90M | 6.95% |
| Dec 31, 2020 | 56.11M | 1.95M | 3.60% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Green Thumb Industries | 1.64B |
| dentalcorp Holdings | 1.55B |
| Sienna Senior Living | 893.16M |
| Trulieve Cannabis | 1.71B |
| Extendicare | 1.47B |
| WELL Health Technologies | 919.69M |
| Curaleaf Holdings | 1.93B |
| Cronos Group | 169.23M |
HLS Therapeutics News
- 6 weeks ago - HLS Therapeutics GAAP EPS of -$0.10, revenue of $15.5M misses by $0.2M - Seeking Alpha
- 6 weeks ago - HLS Therapeutics Announces Fiscal 2024 Financial Results and Normal Course Issuer Bid - Benzinga
- 6 months ago - HLS Therapeutics GAAP EPS of -$0.15 beats by $0.04, revenue of $14.08M misses by $6.42M - Seeking Alpha
- 9 months ago - HLS Therapeutics GAAP EPS of -$0.18, revenue of $14.52M - Seeking Alpha